查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1725100

2032 年乳糖酶市场预测：按类型、来源、形式、分销管道、应用和地区进行的全球分析

Lactase Market Forecasts to 2032 - Global Analysis By Type (Neutral Lactase, Acid Lactase, and Other Types), Source, Form, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球乳糖酶市场规模预计在 2025 年达到 3.1374 亿美元，到 2032 年将达到 5.4825 亿美元，预测期内的复合年增长率为 8.3%。

乳糖酶是小肠产生的一种酶，它将牛奶和乳製品中的乳糖分解成两种简单的糖，即葡萄糖和半乳糖。这个过程对于身体正确消化和吸收乳糖至关重要。乳糖不耐症患者的乳糖酶产生减少，食用乳製品时会出现消化不良。乳糖酶补充剂通常用于减轻症状。它在维持健康消化方面发挥着重要作用，尤其是在儿童早期。

根据美国国家生物技术资讯中心（NCBI）的数据，全球近65%的人口容易罹患乳糖酶缺乏症。

乳糖不耐症盛行率不断上升

随着患有消化器官系统问题的人寻求有效的治疗方法，食品和药物中乳糖酶的使用正在增加。人们对乳糖不耐症的认识不断提高，促使消费者寻找乳製品替代品和消化补充剂。此外，科学研究不断强调乳糖酶补充剂的好处，有助于推动市场采用。政府和医疗保健组织正在积极推动宣传宣传活动，进一步促进市场成长。因此，乳糖不耐症盛行率的上升是乳糖酶市场发展的主要驱动力。

严格的监管要求

为了确保乳糖酶产品的有效性和安全性，製造商必须满足严格的品管要求。乳糖酶製剂的核准过程可能很长，导致产品上市延迟。此外，遵守国际贸易法规也为寻求扩大市场的公司增加了复杂性。食品和药品安全法规的地区差异也阻碍了无缝市场渗透。

对乳製品替代品的需求不断增长

植物来源奶和非乳製品在註重健康和乳糖不耐症的消费者中越来越受欢迎。食品製造商越来越多地将乳糖酶加入到他们的乳製品替代品中，以提高消化率，同时保持口感和质地。素食和弹性素食的兴起进一步刺激了对无乳製品的需求。投资开发无乳糖产品的公司准备利用这个不断扩大的细分市场。食品技术的进步不断提高乳製品替代品的品质和可用性。

替代消化助剂的可用性

乳糖不耐症的消费者可以选择各种益生菌和酵素补充剂来帮助消化，而无需依赖乳糖酶。此外，无乳配方不需要基于乳糖酶的解决方案，这可能会限制市场扩张。为了解决乳糖消化问题，一些消费者转向发酵食品等自然疗法。消化器官系统补充剂领域的持续技术创新可能会进一步加剧市场竞争。随着消费者偏好的不断变化，公司需要使其产品具有差异化，以保持相关性。

COVID-19的影响

COVID-19 疫情对乳糖酶市场产生了多方面影响，影响了生产、分销和消费者需求。供应链中断导致原料短缺，暂时影响了乳糖酶的供应。然而，疫情期间健康意识的增强促使消费者寻求消化器官系统健康解决方案，从而增加了市场兴趣。疫情过后，机能性食品和膳食补充剂的需求持续成长，有利于乳糖酶产品的推广。此外，人们对免疫支持食品配方的研究也越来越多，其中强化乳糖酶的乳製品提供了间接益处。

中性乳糖酶市场预计将在预测期内占据最大份额

由于中性乳糖酶在食品和製药行业的广泛应用，预计将在预测期内占据最大的市场占有率。该部门致力于提高各种产品配方的稳定性和功能性，在不影响口感的情况下提高消化率。中性乳糖酶也广泛应用于婴儿营养和医疗领域。它能够在各种 pH 条件下有效发挥作用，进一步增强了其市场吸引力。

预计在预测期内，製药业将以最高的复合年增长率成长。

预计在预测期内，製药业将出现最高的成长率。乳糖酶越来越多地被添加到药物和膳食补充剂中，以改善消化器官系统健康。此外，医疗保健专业人员建议采用基于乳糖酶的治疗方法来增强患者的消化酶平衡。酵素製剂技术的进步进一步支持了乳糖酶的药物应用。

比最大的地区

在预测期内，亚太地区预计将占据最大的市场占有率，这得益于其强大的乳品加工业和不断上升的乳糖不耐症盛行率。中国、印度和日本等国的消费者对无乳糖乳製品的兴趣日益浓厚。政府推出的促进消化器官系统健康意识的法规进一步促进了该地区市场的扩张。此外，酵素製造技术的进步正在支持当地的生产和创新。大型食品和製药公司的存在将加速市场采用和分销策略。

复合年增长率最高的地区：

由于消费者对机能性食品和消化器官系统健康解决方案的强烈偏好，预计北美在预测期内将呈现最高的复合年增长率。无乳糖产品和营养补充剂的日益普及正在推动全部区域市场的扩张。美国和加拿大的公司正在投资研发以增强乳糖酶製剂。对基于酶的解决方案的监管支持正在促进市场成长和创新。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球乳糖酶市场类型

  • 中性乳糖酶
  • 酸性乳糖酶
  • 其他类型

6. 全球乳糖酶市场（依来源）

  • 酵母菌
  • 真菌
  • 细菌

7. 全球乳糖酶市场（依形式）

  • 乳糖酶粉
  • 液体乳糖酶

8. 全球乳糖酶市场依通路划分

  • 超级市场/大卖场
  • 网路商店
  • 专卖店
  • 其他分销管道

9. 全球乳糖酶市场（依应用）

  • 食品/饮料
    • 牛奶
    • 起司
    • 优格
    • 冰淇淋
  • 营养补充品
  • 製药
  • 动物饲料
  • 其他用途

第十章全球乳糖酶市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • DSM
  • Novozymes
  • Kerry Group plc
  • IFF
  • Advanced Enzyme Technologies
  • Amano Enzyme Inc.
  • Chr. Hansen Holding A/S
  • Senson
  • Merck KGaA（Sigma-Aldrich）
  • Antozyme Biotech Pvt. Ltd.
  • Infinita Biotech Private Limited
  • Aumgene Biosciences
  • Biolaxi Enzymes Pvt. Ltd.
  • Creative Enzymes
  • Nature BioScience Pvt. Ltd.
Product Code: SMRC29406

According to Stratistics MRC, the Global Lactase Market is accounted for $313.74 million in 2025 and is expected to reach $548.25 million by 2032 growing at a CAGR of 8.3% during the forecast period. Lactase is an enzyme produced in the small intestine that breaks down lactose, the sugar found in milk and dairy products, into two simpler sugars: glucose and galactose. This process is essential for proper digestion and absorption of lactose in the body. In individuals with lactose intolerance, lactase production is reduced, leading to digestive discomfort when consuming dairy. Lactase supplements are often used to help manage symptoms. It plays a vital role in maintaining healthy digestion, especially in early childhood.

According to the National Center for Biotechnology Information (NCBI), nearly 65% of the global population is prone to lactase deficiency.

Market Dynamics:

Driver:

Rising prevalence of lactose intolerance

The use of lactase enzymes in food and medication is increasing as people with digestive issues look for efficient remedies. Increased awareness regarding lactose intolerance has prompted consumers to look for dairy alternatives and digestive aids. Additionally, scientific research continues to highlight the benefits of lactase supplementation, encouraging greater market adoption. Governments and healthcare organizations are actively promoting awareness campaigns, further supporting market growth. Consequently, the rising prevalence of lactose intolerance is a major driver of the lactase market.

Restraint:

Stringent regulatory requirements

Rigorous quality control requirements must be met by manufacturers in order to guarantee the efficacy and safety of lactase-based products. The approval process for lactase formulations can be lengthy, leading to delays in product launches. Additionally, compliance with international trade regulations adds complexity for companies looking to expand their market reach. Variations in food and drug safety regulations across different regions further hinder seamless market penetration.

Opportunity:

Increasing demand for dairy alternatives

Plant-based milk and dairy-free products have gained traction among health-conscious and lactose-intolerant consumers. Food manufacturers are actively incorporating lactase enzymes to improve the digestibility of dairy alternatives while maintaining taste and texture. The rise of veganism and flexitarian diets further fuels demand for dairy-free options. Companies investing in lactose-free product development are poised to capitalize on this expanding market segment. Advancements in food technology continue to enhance the quality and accessibility of dairy alternatives.

Threat:

Availability of alternative digestion aids

Consumers with lactose intolerance can choose from various probiotics and enzyme supplements that aid digestion without relying on lactase. Additionally, dairy-free formulations eliminate the need for lactase-based solutions, potentially limiting market expansion. Some consumers prefer natural remedies such as fermented foods to manage lactose digestion issues. Continuous innovation in digestive health supplements may further increase competition within the market. Businesses must differentiate their products to maintain relevance amid evolving consumer preferences.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the lactase market, influencing production, distribution, and consumer demand. Supply chain disruptions led to shortages in raw materials, temporarily affecting lactase enzyme availability. However, heightened health awareness during the pandemic encouraged consumers to seek digestive health solutions, boosting market interest. Post-pandemic, the demand for functional foods and nutraceuticals continues to rise, benefiting lactase product adoption. Moreover, research into immune-supportive food formulations increased, indirectly benefiting lactase-enhanced dairy products.

The neutral lactase segment is expected to be the largest during the forecast period

The neutral lactase segment is expected to account for the largest market share during the forecast period, due to its widespread application across food and pharmaceutical industries. This segment offers improved stability and functionality in diverse product formulations, enhancing digestibility without compromising taste. The neutral lactase enzyme is also widely utilized in infant nutrition and medical applications. Its ability to work efficiently across various pH conditions further strengthens its market appeal.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, driven by the rising awareness of lactose-related digestive disorders. Lactase enzymes are increasingly being incorporated into medications and dietary supplements to improve digestive health. Additionally, healthcare professionals recommend lactase-based treatments to enhance digestive enzyme balance in patients. Advancements in enzyme formulation technology further boost pharmaceutical applications for lactase enzymes.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its thriving dairy industry and rising lactose intolerance prevalence. Countries such as China, India, and Japan are witnessing increased consumer interest in lactose-free dairy products. Government regulations promoting digestive health awareness further contribute to market expansion in this region. Additionally, advancements in enzyme manufacturing technology boost local production and innovation. The presence of major food and pharmaceutical companies accelerates market adoption and distribution strategies.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its strong consumer preference for functional food and digestive health solutions. The rising adoption of lactose-free products and dietary supplements fuels market expansion across the region. Companies in the U.S. and Canada are investing in research and development to enhance lactase enzyme formulations. Regulatory support for enzyme-based solutions contributes to market growth and innovation.

Key players in the market

Some of the key players profiled in the Lactase Market include DSM, Novozymes, Kerry Group plc, IFF, Advanced Enzyme Technologies, Amano Enzyme Inc., Chr. Hansen Holding A/S, Senson, Merck KGaA (Sigma-Aldrich), Antozyme Biotech Pvt. Ltd., Infinita Biotech Private Limited, Aumgene Biosciences, Biolaxi Enzymes Pvt. Ltd., Creative Enzymes, and Nature BioScience Pvt. Ltd.

Key Developments:

In March 2025, DSM-firmenich Animal Nutrition & Health has announced a partnership with Zenkei Company Limited, a premier livestock nutrition company, to advance sustainability in Japan's feed and egg production sectors. The two organisations have signed a Memorandum of Understanding (MOU) to implement dsm-firmenich's Sustell(TM), the industry-leading life cycle assessment (LCA) platform to measure and improve the environmental footprint of animal proteins.

In March 2024, Denmark CET. University of California San Diego, among the world's top-20 research universities, and the global leader in biosolutions Novonesis are excited to launch the establishment of a leading research consortium aimed at setting a new standard for collaboration and accelerating discoveries and knowledge in Human Milk Oligosaccharides (HMOs) science.

Types Covered:

  • Neutral Lactase
  • Acid Lactase
  • Other Types

Sources Covered:

  • Yeast
  • Fungi
  • Bacteria

Forms Covered:

  • Powdered Lactase
  • Liquid Lactase

Distribution Channels Covered:

  • Supermarkets/Hypermarkets
  • Online Stores
  • Specialty Stores
  • Other Distribution Channels

Applications Covered:

  • Food & Beverages
  • Dietary Supplements
  • Pharmaceuticals
  • Animal Feed
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Lactase Market, By Type

  • 5.1 Introduction
  • 5.2 Neutral Lactase
  • 5.3 Acid Lactase
  • 5.4 Other Types

6 Global Lactase Market, By Source

  • 6.1 Introduction
  • 6.2 Yeast
  • 6.3 Fungi
  • 6.4 Bacteria

7 Global Lactase Market, By Form

  • 7.1 Introduction
  • 7.2 Powdered Lactase
  • 7.3 Liquid Lactase

8 Global Lactase Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Supermarkets/Hypermarkets
  • 8.3 Online Stores
  • 8.4 Specialty Stores
  • 8.5 Other Distribution Channels

9 Global Lactase Market, By Application

  • 9.1 Introduction
  • 9.2 Food & Beverages
    • 9.2.1 Milk
    • 9.2.2 Cheese
    • 9.2.3 Yogurt
    • 9.2.4 Ice Cream
  • 9.3 Dietary Supplements
  • 9.4 Pharmaceuticals
  • 9.5 Animal Feed
  • 9.6 Other Applications

10 Global Lactase Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 DSM
  • 12.2 Novozymes
  • 12.3 Kerry Group plc
  • 12.4 IFF
  • 12.5 Advanced Enzyme Technologies
  • 12.6 Amano Enzyme Inc.
  • 12.7 Chr. Hansen Holding A/S
  • 12.8 Senson
  • 12.9 Merck KGaA (Sigma-Aldrich)
  • 12.10 Antozyme Biotech Pvt. Ltd.
  • 12.11 Infinita Biotech Private Limited
  • 12.12 Aumgene Biosciences
  • 12.13 Biolaxi Enzymes Pvt. Ltd.
  • 12.14 Creative Enzymes
  • 12.15 Nature BioScience Pvt. Ltd.

List of Tables

  • Table 1 Global Lactase Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Lactase Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Lactase Market Outlook, By Neutral Lactase (2024-2032) ($MN)
  • Table 4 Global Lactase Market Outlook, By Acid Lactase (2024-2032) ($MN)
  • Table 5 Global Lactase Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 6 Global Lactase Market Outlook, By Source (2024-2032) ($MN)
  • Table 7 Global Lactase Market Outlook, By Yeast (2024-2032) ($MN)
  • Table 8 Global Lactase Market Outlook, By Fungi (2024-2032) ($MN)
  • Table 9 Global Lactase Market Outlook, By Bacteria (2024-2032) ($MN)
  • Table 10 Global Lactase Market Outlook, By Form (2024-2032) ($MN)
  • Table 11 Global Lactase Market Outlook, By Powdered Lactase (2024-2032) ($MN)
  • Table 12 Global Lactase Market Outlook, By Liquid Lactase (2024-2032) ($MN)
  • Table 13 Global Lactase Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 14 Global Lactase Market Outlook, By Supermarkets/Hypermarkets (2024-2032) ($MN)
  • Table 15 Global Lactase Market Outlook, By Online Stores (2024-2032) ($MN)
  • Table 16 Global Lactase Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 17 Global Lactase Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 18 Global Lactase Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Lactase Market Outlook, By Food & Beverages (2024-2032) ($MN)
  • Table 20 Global Lactase Market Outlook, By Milk (2024-2032) ($MN)
  • Table 21 Global Lactase Market Outlook, By Cheese (2024-2032) ($MN)
  • Table 22 Global Lactase Market Outlook, By Yogurt (2024-2032) ($MN)
  • Table 23 Global Lactase Market Outlook, By Ice Cream (2024-2032) ($MN)
  • Table 24 Global Lactase Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 25 Global Lactase Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 26 Global Lactase Market Outlook, By Animal Feed (2024-2032) ($MN)
  • Table 27 Global Lactase Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.